Annual EBITDA
-$10.11 M
-$178.00 K-1.79%
December 1, 2024
Summary
- As of March 9, 2025, ARTL annual EBITDA is -$10.11 million, with the most recent change of -$178.00 thousand (-1.79%) on December 1, 2024.
- During the last 3 years, ARTL annual EBITDA has fallen by -$6.07 million (-150.51%).
- ARTL annual EBITDA is now -66400.00% below its all-time high of -$15.20 thousand, reached on August 31, 2015.
Performance
ARTL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.81 M
-$2.62 M-219.00%
December 1, 2024
Summary
- As of March 9, 2025, ARTL quarterly EBITDA is -$3.81 million, with the most recent change of -$2.62 million (-219.00%) on December 1, 2024.
- Over the past year, ARTL quarterly EBITDA has dropped by -$1.30 million (-51.75%).
- ARTL quarterly EBITDA is now -762300.00% below its all-time high of -$500.00, reached on August 31, 2014.
Performance
ARTL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$10.11 M
-$572.00 K-6.00%
December 1, 2024
Summary
- As of March 9, 2025, ARTL TTM EBITDA is -$10.11 million, with the most recent change of -$572.00 thousand (-6.00%) on December 1, 2024.
- Over the past year, ARTL TTM EBITDA has increased by +$847.00 thousand (+7.73%).
- ARTL TTM EBITDA is now -153051.52% below its all-time high of -$6600.00, reached on February 28, 2014.
Performance
ARTL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ARTL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.8% | -51.8% | +7.7% |
| 3 y3 years | -150.5% | -49.4% | -18.2% |
| 5 y5 years | -115.7% | -165.5% | -111.2% |
ARTL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -150.5% | at low | -219.0% | at low | -17.1% | +7.7% |
| 5 y | 5-year | -215.0% | at low | -300.7% | at low | -119.7% | +7.7% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low | <-9999.0% | +7.7% |
Artelo Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$10.11 M(+1.8%) | -$3.81 M(+219.0%) | -$10.11 M(+6.0%) |
| Sep 2024 | - | -$1.20 M(-52.4%) | -$9.54 M(-13.0%) |
| Jun 2024 | - | -$2.51 M(-3.0%) | -$10.96 M(+7.1%) |
| Mar 2024 | - | -$2.59 M(-20.1%) | -$10.23 M(+3.0%) |
| Dec 2023 | -$9.93 M(-1.5%) | -$3.24 M(+23.9%) | -$9.93 M(-1.0%) |
| Sep 2023 | - | -$2.61 M(+46.5%) | -$10.03 M(+3.0%) |
| Jun 2023 | - | -$1.78 M(-22.2%) | -$9.74 M(-6.6%) |
| Mar 2023 | - | -$2.29 M(-31.4%) | -$10.43 M(+3.4%) |
| Dec 2022 | -$10.08 M(+149.8%) | -$3.34 M(+43.6%) | -$10.08 M(+8.5%) |
| Sep 2022 | - | -$2.33 M(-5.9%) | -$9.29 M(+5.0%) |
| Jun 2022 | - | -$2.47 M(+27.0%) | -$8.85 M(+2.5%) |
| Mar 2022 | - | -$1.95 M(-23.7%) | -$8.63 M(+0.9%) |
| Dec 2021 | -$4.04 M(-45.7%) | - | - |
| Nov 2021 | - | -$2.55 M(+35.5%) | -$8.55 M(+15.0%) |
| Aug 2021 | -$7.44 M(+58.7%) | -$1.88 M(-16.4%) | -$7.44 M(+13.0%) |
| May 2021 | - | -$2.25 M(+20.6%) | -$6.58 M(+24.6%) |
| Feb 2021 | - | -$1.87 M(+30.0%) | -$5.28 M(+10.4%) |
| Nov 2020 | - | -$1.44 M(+39.7%) | -$4.79 M(+2.1%) |
| Aug 2020 | -$4.69 M(+46.0%) | -$1.03 M(+8.0%) | -$4.69 M(+1.6%) |
| May 2020 | - | -$951.30 K(-30.6%) | -$4.61 M(+0.2%) |
| Feb 2020 | - | -$1.37 M(+2.6%) | -$4.60 M(+15.4%) |
| Nov 2019 | - | -$1.34 M(+40.2%) | -$3.99 M(+24.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Aug 2019 | -$3.21 M(+36.9%) | -$953.30 K(+1.3%) | -$3.21 M(+8.9%) |
| May 2019 | - | -$941.00 K(+24.2%) | -$2.95 M(+14.1%) |
| Feb 2019 | - | -$757.80 K(+36.1%) | -$2.58 M(-1.5%) |
| Nov 2018 | - | -$556.80 K(-19.3%) | -$2.62 M(+11.9%) |
| Aug 2018 | -$2.34 M(+906.5%) | -$690.00 K(+19.4%) | -$2.34 M(+32.5%) |
| May 2018 | - | -$577.80 K(-27.6%) | -$1.77 M(+37.5%) |
| Feb 2018 | - | -$798.40 K(+188.2%) | -$1.29 M(+157.2%) |
| Nov 2017 | - | -$277.00 K(+139.6%) | -$500.30 K(+114.9%) |
| Aug 2017 | -$232.80 K(+683.8%) | -$115.60 K(+20.8%) | -$232.80 K(+91.6%) |
| May 2017 | - | -$95.70 K(+697.5%) | -$121.50 K(+294.5%) |
| Feb 2017 | - | -$12.00 K(+26.3%) | -$30.80 K(+28.9%) |
| Nov 2016 | - | -$9500.00(+120.9%) | -$23.90 K(-19.3%) |
| Aug 2016 | -$29.70 K(+95.4%) | -$4300.00(-14.0%) | -$29.60 K(-1.0%) |
| May 2016 | - | -$5000.00(-2.0%) | -$29.90 K(+9.1%) |
| Feb 2016 | - | -$5100.00(-66.4%) | -$27.40 K(-3.9%) |
| Nov 2015 | - | -$15.20 K(+230.4%) | -$28.50 K(+86.3%) |
| Aug 2015 | -$15.20 K(-0.7%) | -$4600.00(+84.0%) | -$15.30 K(+36.6%) |
| May 2015 | - | -$2500.00(-59.7%) | -$11.20 K(-33.3%) |
| Feb 2015 | - | -$6200.00(+210.0%) | -$16.80 K(-2.3%) |
| Nov 2014 | - | -$2000.00(+300.0%) | -$17.20 K(+13.2%) |
| Aug 2014 | -$15.30 K | -$500.00(-93.8%) | -$15.20 K(+3.4%) |
| May 2014 | - | -$8100.00(+22.7%) | -$14.70 K(+122.7%) |
| Feb 2014 | - | -$6600.00 | -$6600.00 |
FAQ
- What is Artelo Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Artelo Biosciences?
- What is Artelo Biosciences annual EBITDA year-on-year change?
- What is Artelo Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Artelo Biosciences?
- What is Artelo Biosciences quarterly EBITDA year-on-year change?
- What is Artelo Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Artelo Biosciences?
- What is Artelo Biosciences TTM EBITDA year-on-year change?
What is Artelo Biosciences annual EBITDA?
The current annual EBITDA of ARTL is -$10.11 M
What is the all time high annual EBITDA for Artelo Biosciences?
Artelo Biosciences all-time high annual EBITDA is -$15.20 K
What is Artelo Biosciences annual EBITDA year-on-year change?
Over the past year, ARTL annual EBITDA has changed by -$178.00 K (-1.79%)
What is Artelo Biosciences quarterly EBITDA?
The current quarterly EBITDA of ARTL is -$3.81 M
What is the all time high quarterly EBITDA for Artelo Biosciences?
Artelo Biosciences all-time high quarterly EBITDA is -$500.00
What is Artelo Biosciences quarterly EBITDA year-on-year change?
Over the past year, ARTL quarterly EBITDA has changed by -$1.30 M (-51.75%)
What is Artelo Biosciences TTM EBITDA?
The current TTM EBITDA of ARTL is -$10.11 M
What is the all time high TTM EBITDA for Artelo Biosciences?
Artelo Biosciences all-time high TTM EBITDA is -$6600.00
What is Artelo Biosciences TTM EBITDA year-on-year change?
Over the past year, ARTL TTM EBITDA has changed by +$847.00 K (+7.73%)